HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Discrimination within epitope specific antibody populations against Classical swine fever virus is a new means of differentiating infection from vaccination.

Abstract
Serological differentiation between infection and vaccination depends on the detection of pathogen specific antibodies for an epitope that is modified or lacking in a vaccine. Here we describe a new assay principle that is based on differences in the binding properties of epitope specific antibodies. C-DIVA is a potent Classical swine fever vaccine candidate that differs from the parental C-strain life attenuated vaccine in the highly immunogenic TAVSPTTLR epitope by the deletion of two and the mutation of one amino acid (TAGSΔΔTLR). We show that C-DIVA vaccination elicits antibodies with high affinity for both the TAGSΔΔTLR and TAVSPTTLR epitope, whereas infection elicits only TAVSPTTLR specific antibodies. Differentiation is achieved with a double competition assay with negative selection for antibodies with affinity for the TAGSΔΔTLR epitope followed by positive selection for antibodies with affinity for the TAVSPTTLR epitope. Our findings add a new strategy for the development of marker vaccines and their accompanying discrimination assays and offer an alternative to the devastating stamping out policy for Classical swine fever.
AuthorsUrs Bruderer, Jan van de Velde, Inge Frantzen, Francesca De Bortoli
JournalJournal of immunological methods (J Immunol Methods) Vol. 420 Pg. 18-23 (May 2015) ISSN: 1872-7905 [Electronic] Netherlands
PMID25825375 (Publication Type: Journal Article)
CopyrightCopyright © 2015 Elsevier B.V. All rights reserved.
Chemical References
  • Antibodies, Viral
  • Epitopes
  • Viral Vaccines
Topics
  • Animals
  • Antibodies, Viral (immunology)
  • Antibody Affinity
  • Antibody Specificity
  • Classical Swine Fever (immunology, prevention & control)
  • Classical Swine Fever Virus (immunology)
  • Epitopes (immunology)
  • Swine
  • Viral Vaccines (immunology, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: